BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Michael-Robinson JM, Biemer-Hüttmann A, Purdie DM, Walsh MD, Simms LA, Biden KG, Young JP, Leggett BA, Jass JR, Radford-Smith GL. Tumor infiltrating lymphocytes and apoptosis are independent features in colorectal cancer stratified according to microsatellite instability status. Gut. 2001;48:360-366. [PMID: 11171826 DOI: 10.1136/gut.48.3.360] [Cited by in Crossref: 128] [Cited by in F6Publishing: 131] [Article Influence: 6.1] [Reference Citation Analysis]
Number Citing Articles
1 Kunac N, Šundov Ž, Vilović K. Apoptosis as a Prognostic Factor in Colorectal Carcinoma: Comparison of TUNEL Method and Immunohistochemical Expression of Caspase-3. Appl Immunohistochem Mol Morphol 2019;27:e22-7. [PMID: 29489504 DOI: 10.1097/PAI.0000000000000623] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
2 von Knebel Doeberitz M, Kloor M. Towards a vaccine to prevent cancer in Lynch syndrome patients. Familial Cancer 2013;12:307-12. [DOI: 10.1007/s10689-013-9662-7] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 3.9] [Reference Citation Analysis]
3 Sipos F, Műzes G. Isolated lymphoid follicles in colon: Switch points between inflammation and colorectal cancer? World J Gastroenterol 2011; 17(13): 1666-1673 [PMID: 21483625 DOI: 10.3748/wjg.v17.i13.1666] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
4 Simonson WT, Allison KH. Tumour-infiltrating lymphocytes in cancer: implications for the diagnostic pathologist. Diagnostic Histopathology 2011;17:80-90. [DOI: 10.1016/j.mpdhp.2010.10.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
5 Ruszkiewicz A, Bennett G, Moore J, Manavis J, Rudzki B, Shen L, Suthers G. Correlation of mismatch repair genes immunohistochemistry and microsatellite instability status in HNPCC-associated tumours. Pathology 2002;34:541-7. [DOI: 10.1080/0031302021000035965-2] [Cited by in Crossref: 60] [Cited by in F6Publishing: 56] [Article Influence: 3.0] [Reference Citation Analysis]
6 Løvig T, Andersen SN, Thorstensen L, Diep CB, Meling GI, Lothe RA, Rognum TO. Strong HLA-DR expression in microsatellite stable carcinomas of the large bowel is associated with good prognosis. Br J Cancer 2002;87:756-62. [PMID: 12232760 DOI: 10.1038/sj.bjc.6600507] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 2.3] [Reference Citation Analysis]
7 Banerjea A, Bustin SA, Dorudi S. The immunogenicity of colorectal cancers with high-degree microsatellite instability. World J Surg Oncol. 2005;3:26. [PMID: 15890075 DOI: 10.1186/1477-7819-3-26] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 2.2] [Reference Citation Analysis]
8 Michael-Robinson JM, Pandeya N, Walsh MD, Biemer-Huttmann AE, Eri RD, Buttenshaw RL, Lincoln D, Clouston AD, Jass JR, Radford-Smith GL. Characterization of tumour-infiltrating lymphocytes and apoptosis in colitis-associated neoplasia: comparison with sporadic colorectal cancer. J Pathol 2006;208:381-7. [PMID: 16315333 DOI: 10.1002/path.1895] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
9 Herath NI, Leggett BA, MacDonald GA. Review of genetic and epigenetic alterations in hepatocarcinogenesis. J Gastroenterol Hepatol. 2006;21:15-21. [PMID: 16706806 DOI: 10.1111/j.1440-1746.2005.04043.x] [Cited by in Crossref: 111] [Cited by in F6Publishing: 104] [Article Influence: 7.4] [Reference Citation Analysis]
10 Kono K, Takahashi A, Amemiya H, Ichihara F, Sugai H, Iizuka H, Fujii H, Matsumoto Y. Frequencies of HER-2/neu overexpression relating to HLA haplotype in patients with gastric cancer. Int J Cancer 2002;98:216-20. [DOI: 10.1002/ijc.10179] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
11 Young Y, Terdiman JP. Endoscopic Management of Familial Colonic Neoplasia. Gastrointestinal Endoscopy Clinics of North America 2005;15:549-80. [DOI: 10.1016/j.giec.2005.03.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
12 Sloan EA, Moskaluk CA, Mills AM. Mucinous Differentiation With Tumor Infiltrating Lymphocytes Is a Feature of Sporadically Methylated Endometrial Carcinomas: . International Journal of Gynecological Pathology 2017;36:205-16. [DOI: 10.1097/pgp.0000000000000315] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
13 Petersson F, Šíma R, Sperga M, Kazakov DV, Michal M, Hora M, Ferda J, Šulc M, Mičulka P, Haferník J, Rychnovský J, Hes O. Lymphocyte-rich Renal Cell Carcinoma: An Unusual Histomorphologic Manifestation of a Tumor That is not Part of Lynch Syndrome. Applied Immunohistochemistry & Molecular Morphology 2011;19:519-27. [DOI: 10.1097/pai.0b013e31821a931f] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
14 Ziadi S, Ksiaa F, Gacem RB, Labaied N, Mokni M, Trimeche M. Clinicopathologic characteristics of colorectal cancer with microsatellite instability. Pathology - Research and Practice 2014;210:98-104. [DOI: 10.1016/j.prp.2013.10.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
15 Ruszkiewicz AR, Jass JR. Microsatellite Instability in Colorectal Cancer: What, How, When, and Why? Pathology Case Reviews 2004;9:163-72. [DOI: 10.1097/01.pcr.0000132991.85133.ef] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
16 Hirano D, Urabe Y, Tanaka S, Nakamura K, Ninomiya Y, Yuge R, Hayashi R, Oka S, Kitadai Y, Shimamoto F, Arihiro K, Chayama K. Early-stage serrated adenocarcinomas are divided into several molecularly distinct subtypes. PLoS One 2019;14:e0211477. [PMID: 30785889 DOI: 10.1371/journal.pone.0211477] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
17 Basa RC, Davies V, Li X, Murali B, Shah J, Yang B, Li S, Khan MW, Tian M, Tejada R, Hassan A, Washington A Jr, Mukherjee B, Carethers JM, McGuire KL. Decreased Anti-Tumor Cytotoxic Immunity among Microsatellite-Stable Colon Cancers from African Americans. PLoS One 2016;11:e0156660. [PMID: 27310868 DOI: 10.1371/journal.pone.0156660] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
18 Turner N, Wong HL, Templeton A, Tripathy S, Whiti Rogers T, Croxford M, Jones I, Sinnathamby M, Desai J, Tie J, Bae S, Christie M, Gibbs P, Tran B. Analysis of local chronic inflammatory cell infiltrate combined with systemic inflammation improves prognostication in stage II colon cancer independent of standard clinicopathologic criteria. Int J Cancer. 2016;138:671-678. [PMID: 26270488 DOI: 10.1002/ijc.29805] [Cited by in Crossref: 33] [Cited by in F6Publishing: 43] [Article Influence: 4.7] [Reference Citation Analysis]
19 Colomer A, Erill N, Vidal A, Calvo M, Roman R, Verdú M, Cordon-Cardo C, Puig X. A novel logistic model based on clinicopathological features predicts microsatellite instability in colorectal carcinomas. Diagn Mol Pathol 2005;14:213-23. [PMID: 16319691 DOI: 10.1097/01.pas.0000177800.65959.48] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
20 Fenwick SW, Toogood GJ, Lodge JA, Hull MA. The effect of the selective cyclooxygenase-2 inhibitor rofecoxib on human colorectal cancer liver metastases. Gastroenterology 2003;125:716-29. [DOI: 10.1016/s0016-5085(03)01061-8] [Cited by in Crossref: 55] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
21 Koornstra JJ, Kleibeuker JH, van Geelen CM, Rijcken FE, Hollema H, de Vries EG, de Jong S. Expression of TRAIL (TNF-related apoptosis-inducing ligand) and its receptors in normal colonic mucosa, adenomas, and carcinomas: TRAIL and its receptors in colon adenomas and carcinomas. J Pathol 2003;200:327-35. [DOI: 10.1002/path.1364] [Cited by in Crossref: 97] [Cited by in F6Publishing: 89] [Article Influence: 5.1] [Reference Citation Analysis]
22 Qi Q, Zhuang L, Shen Y, Geng Y, Yu S, Chen H, Liu L, Meng Z, Wang P, Chen Z. A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy. Cancer 2016;122:2158-67. [PMID: 27152949 DOI: 10.1002/cncr.30057] [Cited by in Crossref: 86] [Cited by in F6Publishing: 85] [Article Influence: 14.3] [Reference Citation Analysis]
23 Ooki A, Akagi K, Yatsuoka T, Asayama M, Hara H, Nishimura Y, Katoh H, Yamashita K, Watanabe M, Yamaguchi K. Lymph Node Ratio as a Risk Factor for Recurrence After Adjuvant Chemotherapy in Stage III Colorectal Cancer. J Gastrointest Surg 2017;21:867-78. [PMID: 28251467 DOI: 10.1007/s11605-017-3382-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
24 Breakstone R. Colon cancer and immunotherapy-can we go beyond microsatellite instability? Transl Gastroenterol Hepatol 2021;6:12. [PMID: 33409406 DOI: 10.21037/tgh.2020.03.08] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Hacking SM, Chakraborty B, Nasim R, Vitkovski T, Thomas R. A Holistic Appraisal of Stromal Differentiation in Colorectal Cancer: Biology, Histopathology, Computation, and Genomics. Pathol Res Pract 2021;220:153378. [PMID: 33690050 DOI: 10.1016/j.prp.2021.153378] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
26 Jass JR. HNPCC and sporadic MSI-H colorectal cancer: a review of the morphological similarities and differences. Fam Cancer. 2004;3:93-100. [PMID: 15340259 DOI: 10.1023/b:fame.0000039849.86008.b7] [Cited by in Crossref: 105] [Cited by in F6Publishing: 50] [Article Influence: 5.8] [Reference Citation Analysis]
27 Lugli A, Karamitopoulou E, Panayiotides I, Karakitsos P, Rallis G, Peros G, Iezzi G, Spagnoli G, Bihl M, Terracciano L. CD8+ lymphocytes/ tumour-budding index: an independent prognostic factor representing a ‘pro-/anti-tumour’ approach to tumour host interaction in colorectal cancer. Br J Cancer. 2009;101:1382-1392. [PMID: 19755986 DOI: 10.1038/sj.bjc.6605318] [Cited by in Crossref: 79] [Cited by in F6Publishing: 82] [Article Influence: 6.1] [Reference Citation Analysis]
28 Millen R, Malaterre J, Cross RS, Carpinteri S, Desai J, Tran B, Darcy P, Gibbs P, Sieber O, Zeps N, Waring P, Fox S, Pereira L, Ramsay RG. Immunomodulation by MYB is associated with tumor relapse in patients with early stage colorectal cancer. Oncoimmunology 2016;5:e1149667. [PMID: 27622014 DOI: 10.1080/2162402X.2016.1149667] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
29 Fantini MC, Favale A, Onali S, Facciotti F. Tumor Infiltrating Regulatory T Cells in Sporadic and Colitis-Associated Colorectal Cancer: The Red Little Riding Hood and the Wolf. Int J Mol Sci 2020;21:E6744. [PMID: 32937953 DOI: 10.3390/ijms21186744] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
30 Smith CL, Dulphy N, Salio M, Cerundolo V. Immunotherapy of colorectal cancer. Br Med Bull 2002;64:181-200. [PMID: 12421733 DOI: 10.1093/bmb/64.1.181] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
31 Tamas K, Walenkamp AM, de Vries EG, van Vugt MA, Beets-Tan RG, van Etten B, de Groot DJ, Hospers GA. Rectal and colon cancer: Not just a different anatomic site. Cancer Treat Rev. 2015;41:671-679. [PMID: 26145760 DOI: 10.1016/j.ctrv.2015.06.007] [Cited by in Crossref: 131] [Cited by in F6Publishing: 129] [Article Influence: 18.7] [Reference Citation Analysis]
32 Abdelrazeq AS. Spontaneous regression of colorectal cancer: a review of cases from 1900 to 2005. Int J Colorectal Dis. 2007;22:727-736. [PMID: 17146588 DOI: 10.1007/s00384-006-0245-z] [Cited by in Crossref: 37] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
33 Gbolahan O, O'Neil B. Update on systemic therapy for colorectal cancer: biologics take sides. Transl Gastroenterol Hepatol 2019;4:9. [PMID: 30976712 DOI: 10.21037/tgh.2019.01.12] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
34 Drescher KM, Lynch HT. Tumor infiltrating lymphocytes (TILs): Lessons learned in 30 years of study. Clinical and Applied Immunology Reviews 2005;5:149-66. [DOI: 10.1016/j.cair.2005.03.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
35 Greenson JK, Huang SC, Herron C, Moreno V, Bonner JD, Tomsho LP, Ben-Izhak O, Cohen HI, Trougouboff P, Bejhar J. Pathologic predictors of microsatellite instability in colorectal cancer. Am J Surg Pathol. 2009;33:126-133. [PMID: 18830122 DOI: 10.1097/pas.0b013e31817ec2b1] [Cited by in Crossref: 138] [Cited by in F6Publishing: 58] [Article Influence: 10.6] [Reference Citation Analysis]
36 Giráldez MD, Castellví-Bel S, Balaguer F, Gonzalo V, Ocaña T, Castells A. Lynch syndrome in colorectal cancer patients. Expert Rev Anticancer Ther 2008;8:573-83. [PMID: 18402524 DOI: 10.1586/14737140.8.4.573] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
37 Kasajima A, Sers C, Sasano H, Jöhrens K, Stenzinger A, Noske A, Buckendahl A, Darb-esfahani S, Müller BM, Budczies J, Lehman A, Dietel M, Denkert C, Weichert W. Down-regulation of the antigen processing machinery is linked to a loss of inflammatory response in colorectal cancer. Human Pathology 2010;41:1758-69. [DOI: 10.1016/j.humpath.2010.05.014] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 3.8] [Reference Citation Analysis]
38 Menon AG, Janssen-van Rhijn CM, Morreau H, Putter H, Tollenaar RA, van de Velde CJ, Fleuren GJ, Kuppen PJ. Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis. Lab Invest. 2004;84:493-501. [PMID: 14968119 DOI: 10.1038/labinvest.3700055] [Cited by in Crossref: 161] [Cited by in F6Publishing: 145] [Article Influence: 8.9] [Reference Citation Analysis]
39 Román R, Verdú M, Calvo M, Vidal A, Sanjuan X, Jimeno M, Salas A, Autonell J, Trias I, González M, García B, Rodón N, Puig X. Microsatellite instability of the colorectal carcinoma can be predicted in the conventional pathologic examination. A prospective multicentric study and the statistical analysis of 615 cases consolidate our previously proposed logistic regression model. Virchows Arch 2010;456:533-41. [PMID: 20393748 DOI: 10.1007/s00428-010-0896-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
40 Halvarsson B, Müller W, Planck M, Benoni AC, Mangell P, Ottosson J, Hallén M, Isinger A, Nilbert M. Phenotypic heterogeneity in hereditary non-polyposis colorectal cancer: identical germline mutations associated with variable tumour morphology and immunohistochemical expression. J Clin Pathol 2007;60:781-6. [PMID: 16901974 DOI: 10.1136/jcp.2006.040402] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
41 Michael-Robinson JM, Pandeya N, Cummings MC, Walsh MD, Young JP, Leggett BA, Purdie DM, Jass JR, Radford-Smith GL. Fas ligand and tumour counter-attack in colorectal cancer stratified according to microsatellite instability status. J Pathol. 2003;201:46-54. [PMID: 12950016 DOI: 10.1002/path.1406] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
42 Salama P, Platell C. Host response to colorectal cancer. ANZ J Surg. 2008;78:745-753. [PMID: 18844901 DOI: 10.1111/j.1445-2197.2008.04642.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
43 Dahlin AM, Henriksson ML, Van Guelpen B, Stenling R, Oberg A, Rutegård J, Palmqvist R. Colorectal cancer prognosis depends on T-cell infiltration and molecular characteristics of the tumor. Mod Pathol 2011;24:671-82. [PMID: 21240258 DOI: 10.1038/modpathol.2010.234] [Cited by in Crossref: 137] [Cited by in F6Publishing: 131] [Article Influence: 12.5] [Reference Citation Analysis]
44 Greenson JK, Bonner JD, Ben-Yzhak O, Cohen HI, Miselevich I, Resnick MB, Trougouboff P, Tomsho LD, Kim E, Low M. Phenotype of microsatellite unstable colorectal carcinomas: Well-differentiated and focally mucinous tumors and the absence of dirty necrosis correlate with microsatellite instability. Am J Surg Pathol. 2003;27:563-570. [PMID: 12717242 DOI: 10.1097/00000478-200305000-00001] [Cited by in Crossref: 168] [Cited by in F6Publishing: 149] [Article Influence: 8.8] [Reference Citation Analysis]
45 Harvey NT, Ruszkiewicz A. Serrated neoplasia of the colorectum. World J Gastroenterol 2007; 13(28): 3792-3798 [PMID: 17657832 DOI: 10.3748/wjg.v13.i28.3792] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
46 Ogawa T, Yoshida T, Tsuruta T, Saigenji K, Okayasu I. Genetic instability on chromosome 17 in the epithelium of non-polypoid colorectal carcinomas compared to polypoid lesions. Cancer Science 2006;97:1335-42. [DOI: 10.1111/j.1349-7006.2006.00334.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
47 Borda F, Martínez-Peñuela JM, Borda A, Muñoz-Navas M, Jiménez J, Carretero C. [Predictive value of intraepithelial (CD3) T-lymphocyte infiltration in resected colorectal cancer]. Gastroenterol Hepatol 2012;35:541-50. [PMID: 22858112 DOI: 10.1016/j.gastrohep.2012.05.003] [Reference Citation Analysis]
48 Shia J, Ellis NA, Paty PB, Nash GM, Qin J, Offit K, Zhang XM, Markowitz AJ, Nafa K, Guillem JG, Wong WD, Gerald WL, Klimstra DS. Value of histopathology in predicting microsatellite instability in hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer. Am J Surg Pathol 2003;27:1407-17. [PMID: 14576473 DOI: 10.1097/00000478-200311000-00002] [Cited by in Crossref: 160] [Cited by in F6Publishing: 140] [Article Influence: 8.4] [Reference Citation Analysis]
49 Pernot S, Terme M, Voron T, Colussi O, Marcheteau E, Tartour E, Taieb J. Colorectal cancer and immunity: What we know and perspectives. World J Gastroenterol 2014; 20(14): 3738-3750 [PMID: 24833840 DOI: 10.3748/wjg.v20.i14.3738] [Cited by in CrossRef: 79] [Cited by in F6Publishing: 81] [Article Influence: 9.9] [Reference Citation Analysis]
50 Zlobec I, Lugli A. Invasive front of colorectal cancer: Dynamic interface of pro-/anti-tumor factors. World J Gastroenterol 2009; 15(47): 5898-5906 [PMID: 20014453 DOI: 10.3748/wjg.15.5898] [Cited by in CrossRef: 74] [Cited by in F6Publishing: 71] [Article Influence: 5.7] [Reference Citation Analysis]
51 Holck S, Nielsen HJ, Hammer E, Christensen IJ, Larsson L. IQGAP1 in rectal adenocarcinomas: Localization and protein expression before and after radiochemotherapy. Cancer Letters 2015;356:556-60. [DOI: 10.1016/j.canlet.2014.10.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
52 Young J, Simms LA, Biden KG, Wynter C, Whitehall V, Karamatic R, George J, Goldblatt J, Walpole I, Robin SA. Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis. Am J Pathol. 2001;159:2107-2116. [PMID: 11733361 DOI: 10.1016/s0002-9440(10)63062-3] [Cited by in Crossref: 253] [Cited by in F6Publishing: 105] [Article Influence: 12.0] [Reference Citation Analysis]
53 Schneider R, Schneider C, Kloor M, Fürst A, Möslein G. Lynch syndrome: clinical, pathological, and genetic insights. Langenbecks Arch Surg 2012;397:513-25. [PMID: 22362054 DOI: 10.1007/s00423-012-0918-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
54 Ruemmele P, Dietmaier W, Terracciano L, Tornillo L, Bataille F, Kaiser A, Wuensch PH, Heinmoeller E, Homayounfar K, Luettges J. Histopathologic features and microsatellite instability of cancers of the papilla of vater and their precursor lesions. Am J Surg Pathol. 2009;33:691-704. [PMID: 19252434 DOI: 10.1097/pas.0b013e3181983ef7] [Cited by in Crossref: 77] [Cited by in F6Publishing: 38] [Article Influence: 5.9] [Reference Citation Analysis]
55 Bardhan K, Liu K. Epigenetics and colorectal cancer pathogenesis. Cancers (Basel) 2013;5:676-713. [PMID: 24216997 DOI: 10.3390/cancers5020676] [Cited by in Crossref: 142] [Cited by in F6Publishing: 140] [Article Influence: 15.8] [Reference Citation Analysis]
56 de Bruin EC, Medema JP. Apoptosis and non-apoptotic deaths in cancer development and treatment response. Cancer Treatment Reviews 2008;34:737-49. [DOI: 10.1016/j.ctrv.2008.07.001] [Cited by in Crossref: 188] [Cited by in F6Publishing: 179] [Article Influence: 13.4] [Reference Citation Analysis]
57 Roxburgh CS, McMillan DC. The role of the in situ local inflammatory response in predicting recurrence and survival in patients with primary operable colorectal cancer. Cancer Treat Rev 2012;38:451-66. [PMID: 21945823 DOI: 10.1016/j.ctrv.2011.09.001] [Cited by in Crossref: 104] [Cited by in F6Publishing: 100] [Article Influence: 9.5] [Reference Citation Analysis]
58 Toh JWT, Lim SH, MacKenzie S, de Souza P, Bokey L, Chapuis P, Spring KJ. Association Between Microsatellite Instability Status and Peri-Operative Release of Circulating Tumour Cells in Colorectal Cancer. Cells 2020;9:E425. [PMID: 32059485 DOI: 10.3390/cells9020425] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
59 Banerjea A, Ahmed S, Hands RE, Huang F, Han X, Shaw PM, Feakins R, Bustin SA, Dorudi S. Colorectal cancers with microsatellite instability display mRNA expression signatures characteristic of increased immunogenicity. Mol Cancer. 2004;3:21. [PMID: 15298707 DOI: 10.1186/1476-4598-3-21] [Cited by in Crossref: 107] [Cited by in F6Publishing: 99] [Article Influence: 5.9] [Reference Citation Analysis]
60 Deschoolmeester V, Baay M, Van Marck E, Weyler J, Vermeulen P, Lardon F, Vermorken JB. Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients. BMC Immunol. 2010;11:19. [PMID: 20385003 DOI: 10.1186/1471-2172-11-19] [Cited by in Crossref: 139] [Cited by in F6Publishing: 141] [Article Influence: 11.6] [Reference Citation Analysis]
61 Xicola RM, Llor X, Pons E, Castells A, Alenda C, Piñol V, Andreu M, Castellví-Bel S, Payá A, Jover R, Bessa X, Girós A, Duque JM, Nicolás-Pérez D, Garcia AM, Rigau J, Gassull MA; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Performance of different microsatellite marker panels for detection of mismatch repair-deficient colorectal tumors. J Natl Cancer Inst 2007;99:244-52. [PMID: 17284719 DOI: 10.1093/jnci/djk033] [Cited by in Crossref: 120] [Cited by in F6Publishing: 112] [Article Influence: 8.0] [Reference Citation Analysis]
62 Samdani T, Schultheis M, Stadler Z, Shia J, Fancher T, Misholy J, Weiser MR, Nash GM. Lymph node yield after colectomy for cancer: is absence of mismatch repair a factor? Dis Colon Rectum. 2015;58:288-293. [PMID: 25664706 DOI: 10.1097/dcr.0000000000000262] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
63 Koornstra JJ, Rijcken FEM, de Jong S, Hollema H, de Vries EGE, Kleibeuker JH. Assessment of apoptosis by M30 immunoreactivity and the correlation with morphological criteria in normal colorectal mucosa, adenomas and carcinomas. Histopathology 2004;44:9-17. [DOI: 10.1111/j.1365-2559.2004.01739.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
64 Gelfo V, Romaniello D, Mazzeschi M, Sgarzi M, Grilli G, Morselli A, Manzan B, Rihawi K, Lauriola M. Roles of IL-1 in Cancer: From Tumor Progression to Resistance to Targeted Therapies. Int J Mol Sci 2020;21:E6009. [PMID: 32825489 DOI: 10.3390/ijms21176009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
65 Sanchez-Castañón M, Er TK, Bujanda L, Herreros-Villanueva M. Immunotherapy in colorectal cancer: What have we learned so far? Clin Chim Acta 2016;460:78-87. [PMID: 27350293 DOI: 10.1016/j.cca.2016.06.027] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
66 Atreya I, Neurath MF. Immune cells in colorectal cancer: prognostic relevance and therapeutic strategies. Expert Review of Anticancer Therapy 2014;8:561-72. [DOI: 10.1586/14737140.8.4.561] [Cited by in Crossref: 62] [Cited by in F6Publishing: 60] [Article Influence: 7.8] [Reference Citation Analysis]
67 Dalerba P, Maccalli C, Casati C, Castelli C, Parmiani G. Immunology and immunotherapy of colorectal cancer. Critical Reviews in Oncology/Hematology 2003;46:33-57. [DOI: 10.1016/s1040-8428(02)00159-2] [Cited by in Crossref: 93] [Cited by in F6Publishing: 34] [Article Influence: 4.9] [Reference Citation Analysis]
68 Koornstra JJ, de Jong S, Hollema H, de Vries EG, Kleibeuker JH. Changes in apoptosis during the development of colorectal cancer: a systematic review of the literature. Crit Rev Oncol Hematol. 2003;45:37-53. [PMID: 12482571 DOI: 10.1016/s1040-8428(01)00228-1] [Cited by in Crossref: 48] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
69 Tougeron D, Maby P, Elie N, Fauquembergue E, Le Pessot F, Cornic M, Sabourin JC, Michel P, Frébourg T, Latouche JB. Regulatory T lymphocytes are associated with less aggressive histologic features in microsatellite-unstable colorectal cancers. PLoS One 2013;8:e61001. [PMID: 23613769 DOI: 10.1371/journal.pone.0061001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
70 Koornstra JJ, de Jong S, Boersma-van Eck W, Zwart N, Hollema H, de Vries EG, Kleibeuker JH. Fas ligand expression in lynch syndrome-associated colorectal tumours. Pathol Oncol Res 2009;15:399-406. [PMID: 19067240 DOI: 10.1007/s12253-008-9136-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
71 Pancione M, Di Blasi A, Sabatino L, Fucci A, Dalena AM, Palombi N, Carotenuto P, Aquino G, Daniele B, Normanno N, Colantuoni V. A novel case of rhabdoid colon carcinoma associated with a positive CpG island methylator phenotype and BRAF mutation. Hum Pathol 2011;42:1047-52. [PMID: 21315413 DOI: 10.1016/j.humpath.2010.10.016] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
72 Fu KI, Sano Y, Kato S, Fujii T, Koba I, Yoshino T, Ochiai A, Yoshida S, Fujimori T. Incidence and localization of lymphoid follicles in early colorectal neoplasms. World J Gastroenterol 2005;11:6863-6. [PMID: 16425398 DOI: 10.3748/wjg.v11.i43.6863] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
73 Roxburgh CS, Richards CH, Macdonald AI, Powell AG, McGlynn LM, McMillan DC, Horgan PG, Edwards J, Shiels PG. The in situ local immune response, tumour senescence and proliferation in colorectal cancer. Br J Cancer 2013;109:2207-16. [PMID: 24022192 DOI: 10.1038/bjc.2013.556] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
74 El Agy F, Otmani IE, Mazti A, Lahmidani N, Oussaden A, El Abkari M, Benjelloun EB, Moukit W, El Bouhaddouti H, Toughrai I, Hassani KM, Maazaz K, Benbrahim Z, Mellas N, El Rhazi K, Ouldim K, El Bardai S, Adil Ibrahimi S, Ait Taleb K, Bennis S, Laila C. Implication of Microsatellite Instability Pathway in Outcome of Colon Cancer in Moroccan Population. Dis Markers 2019;2019:3210710. [PMID: 31885734 DOI: 10.1155/2019/3210710] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
75 Maccaroni E, Bracci R, Giampieri R, Bianchi F, Belvederesi L, Brugiati C, Pagliaretta S, Del Prete M, Scartozzi M, Cascinu S. Prognostic impact of mismatch repair genes germline defects in colorectal cancer patients: are all mutations equal? Oncotarget 2015;6:38737-48. [PMID: 26485756 DOI: 10.18632/oncotarget.5395] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 3.7] [Reference Citation Analysis]
76 Dierssen JW, de Miranda NF, Mulder A, van Puijenbroek M, Verduyn W, Claas FH, van de Velde CJ, Jan Fleuren G, Cornelisse CJ, Corver WE, Morreau H. High-resolution analysis of HLA class I alterations in colorectal cancer. BMC Cancer 2006;6:233. [PMID: 17014712 DOI: 10.1186/1471-2407-6-233] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
77 Deschoolmeester V, Baay M, Specenier P, Lardon F, Vermorken JB. A review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapy. Oncologist. 2010;15:699-731. [PMID: 20584808 DOI: 10.1634/theoncologist.2010-0025] [Cited by in Crossref: 99] [Cited by in F6Publishing: 95] [Article Influence: 8.3] [Reference Citation Analysis]
78 Bohaumilitzky L, von Knebel Doeberitz M, Kloor M, Ahadova A. Implications of Hereditary Origin on the Immune Phenotype of Mismatch Repair-Deficient Cancers: Systematic Literature Review. J Clin Med 2020;9:E1741. [PMID: 32512823 DOI: 10.3390/jcm9061741] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
79 Shibata N, Watari J, Fujiya M, Tanno S, Saitoh Y, Kohgo Y. Cell kinetics and genetic instabilities in differentiated type early gastric cancers with different mucin phenotype. Hum Pathol. 2003;34:32-40. [PMID: 12605364 DOI: 10.1053/hupa.2003.2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 1.6] [Reference Citation Analysis]
80 Wright CL, Stewart ID. Histopathology and mismatch repair status of 458 consecutive colorectal carcinomas. Am J Surg Pathol 2003;27:1393-406. [PMID: 14576472 DOI: 10.1097/00000478-200311000-00001] [Cited by in Crossref: 62] [Cited by in F6Publishing: 54] [Article Influence: 3.3] [Reference Citation Analysis]
81 Du F, Liu Y. Predictive molecular markers for the treatment with immune checkpoint inhibitors in colorectal cancer. J Clin Lab Anal 2021;:e24141. [PMID: 34817097 DOI: 10.1002/jcla.24141] [Reference Citation Analysis]
82 Musha H, Ohtani H, Mizoi T, Kinouchi M, Nakayama T, Shiiba K, Miyagawa K, Nagura H, Yoshie O, Sasaki I. Selective infiltration of CCR5+CXCR3+ T lymphocytes in human colorectal carcinoma. Int J Cancer 2005;116:949-56. [DOI: 10.1002/ijc.21135] [Cited by in Crossref: 99] [Cited by in F6Publishing: 97] [Article Influence: 5.8] [Reference Citation Analysis]
83 Russo A, Sala P, Alberici P, Gazzoli I, Radice P, Montefusco C, Torrini M, Mareni C, Fornasarig M, Santarosa M, Viel A, Benatti P, Pedroni M, De Leon MP, Lucci-cordisco E, Genuardi M, Messerini L, Stigliano V, Cama A, Curia MC, De Lellis L, Signoroni S, Pierotti MA, Bertario L. Prognostic Relevance of MLH1 and MSH2 Mutations in Hereditary Non-Polyposis Colorectal Cancer Patients. Tumori 2009;95:731-8. [DOI: 10.1177/030089160909500616] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
84 Baker K, Chong G, Foulkes WD, Jass JR. Transforming growth factor-beta pathway disruption and infiltration of colorectal cancers by intraepithelial lymphocytes. Histopathology 2006;49:371-80. [PMID: 16978200 DOI: 10.1111/j.1365-2559.2006.02520.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
85 Kim JC, Kim SY, Roh SA, Cho DH, Kim DD, Kim JH, Kim YS. Gene expression profiling: Canonical molecular changes and clinicopathological features in sporadic colorectal cancers. World J Gastroenterol 2008; 14(43): 6662-6672 [PMID: 19034969 DOI: 10.3748/wjg.14.6662] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
86 Diakos CI, Charles KA, McMillan DC, Clarke SJ. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 2014;15:e493-e503. [PMID: 25281468 DOI: 10.1016/s1470-2045(14)70263-3] [Cited by in Crossref: 667] [Cited by in F6Publishing: 482] [Article Influence: 95.3] [Reference Citation Analysis]
87 Polydorides AD, Mukherjee B, Gruber SB, McKenna BJ, Appelman HD, Greenson JK. Adenoma-infiltrating lymphocytes (AILs) are a potential marker of hereditary nonpolyposis colorectal cancer. Am J Surg Pathol 2008;32:1661-6. [PMID: 18753941 DOI: 10.1097/PAS.0b013e31816ffa80] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
88 Hayashi A, Shibahara J, Misumi K, Arita J, Sakamoto Y, Hasegawa K, Kokudo N, Fukayama M. Histologic Assessment of Intratumoral Lymphoplasmacytic Infiltration Is Useful in Predicting Prognosis of Patients with Hepatocellular Carcinoma. PLoS One 2016;11:e0155744. [PMID: 27195977 DOI: 10.1371/journal.pone.0155744] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
89 Devall MAM, Casey G. Controlling for cellular heterogeneity using single-cell deconvolution of gene expression reveals novel markers of colorectal tumors exhibiting microsatellite instability. Oncotarget 2021;12:767-82. [PMID: 33889300 DOI: 10.18632/oncotarget.27935] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
90 Bernal M, García-alcalde F, Concha A, Cano C, Blanco A, Garrido F, Ruiz-cabello F. Genome-wide differential genetic profiling characterizes colorectal cancers with genetic instability and specific routes to HLA class I loss and immune escape. Cancer Immunol Immunother 2012;61:803-16. [DOI: 10.1007/s00262-011-1147-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
91 Walsh MD, Dent OF, Young JP, Wright CM, Barker MA, Leggett BA, Bokey L, Chapuis PH, Jass JR, Macdonald GA. HLA-DR expression is associated with better prognosis in sporadic Australian clinicopathological Stage C colorectal cancers. Int J Cancer 2009;125:1231-7. [PMID: 19462453 DOI: 10.1002/ijc.24484] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
92 Toh JWT, Ferguson AL, Spring KJ, Mahajan H, Palendira U. Cytotoxic CD8+ T cells and tissue resident memory cells in colorectal cancer based on microsatellite instability and BRAF status. World J Clin Oncol 2021; 12(4): 238-248 [PMID: 33959477 DOI: 10.5306/wjco.v12.i4.238] [Reference Citation Analysis]
93 Mocellin S, Rossi CR, Lise M, Nitti D. Colorectal cancer vaccines: principles, results, and perspectives. Gastroenterology. 2004;127:1821-1837. [PMID: 15578520 DOI: 10.1053/j.gastro.2004.07.012] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
94 Ikeguchi M, Oi K, Hirooka Y, Kaibara N. CD8+ lymphocyte infiltration and apoptosis in hepatocellular carcinoma. Eur J Surg Oncol. 2004;30:53-57. [PMID: 14736523 DOI: 10.1016/j.ejso.2003.10.001] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
95 Zaanan A, Meunier K, Sangar F, Fléjou JF, Praz F. Microsatellite instability in colorectal cancer: from molecular oncogenic mechanisms to clinical implications. Cell Oncol (Dordr) 2011;34:155-76. [PMID: 21484480 DOI: 10.1007/s13402-011-0024-x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 3.4] [Reference Citation Analysis]
96 Maby P, Galon J, Latouche JB. Frameshift mutations, neoantigens and tumor-specific CD8(+) T cells in microsatellite unstable colorectal cancers. Oncoimmunology 2016;5:e1115943. [PMID: 27467916 DOI: 10.1080/2162402X.2015.1115943] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
97 Phillips SM, Banerjea A, Feakins R, Li SR, Bustin SA, Dorudi S. Tumour-infiltrating lymphocytes in colorectal cancer with microsatellite instability are activated and cytotoxic. Br J Surg. 2004;91:469-475. [PMID: 15048750 DOI: 10.1002/bjs.4472] [Cited by in Crossref: 137] [Cited by in F6Publishing: 127] [Article Influence: 7.6] [Reference Citation Analysis]
98 Kim CG, Ahn JB, Jung M, Beom SH, Kim C, Kim JH, Heo SJ, Park HS, Kim JH, Kim NK, Min BS, Kim H, Koom WS, Shin SJ. Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers. Br J Cancer. 2016;115:25-33. [PMID: 27228287 DOI: 10.1038/bjc.2016.161] [Cited by in Crossref: 66] [Cited by in F6Publishing: 58] [Article Influence: 11.0] [Reference Citation Analysis]
99 Horimoto Y, Thinzar Hlaing M, Saeki H, Kitano S, Nakai K, Sasaki R, Kurisaki-Arakawa A, Arakawa A, Otsuji N, Matsuoka S, Tokuda E, Arai M, Saito M. Microsatellite instability and mismatch repair protein expressions in lymphocyte-predominant breast cancer. Cancer Sci 2020;111:2647-54. [PMID: 32449246 DOI: 10.1111/cas.14500] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
100 Roxburgh CS, Shia J, Vakiani E, Daniel T, Weiser MR. Potential immune priming of the tumor microenvironment with FOLFOX chemotherapy in locally advanced rectal cancer. Oncoimmunology 2018;7:e1435227. [PMID: 29872576 DOI: 10.1080/2162402X.2018.1435227] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
101 Deschoolmeester V, Baay M, Lardon F, Pauwels P, Peeters M. Immune Cells in Colorectal Cancer: Prognostic Relevance and Role of MSI. Cancer Microenviron. 2011;4:377-392. [PMID: 21618031 DOI: 10.1007/s12307-011-0068-5] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 4.9] [Reference Citation Analysis]
102 Matsumoto N, Yoshida T, Yamashita K, Numata Y, Okayasu I. Possible alternative carcinogenesis pathway featuring microsatellite instability in colorectal cancer stroma. Br J Cancer 2003;89:707-12. [PMID: 12915883 DOI: 10.1038/sj.bjc.6601141] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
103 Jass JR. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology. 2007;50:113-130. [PMID: 17204026 DOI: 10.1111/j.1365-2559.2006.02549.x] [Cited by in Crossref: 884] [Cited by in F6Publishing: 838] [Article Influence: 58.9] [Reference Citation Analysis]
104 Ishiguro K, Yoshida T, Yagishita H, Numata Y, Okayasu T. Epithelial and stromal genetic instability contributes to genesis of colorectal adenomas. Gut 2006;55:695-702. [PMID: 16354798 DOI: 10.1136/gut.2005.079459] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 3.1] [Reference Citation Analysis]
105 Bredahl EC, Eckerson JM, Tracy SM, McDonald TL, Drescher KM. The Role of Creatine in the Development and Activation of Immune Responses. Nutrients 2021;13:751. [PMID: 33652752 DOI: 10.3390/nu13030751] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
106 Chiaravalli AM, Feltri M, Bertolini V, Bagnoli E, Furlan D, Cerutti R, Novario R, Capella C. Intratumour T cells, their activation status and survival in gastric carcinomas characterised for microsatellite instability and Epstein-Barr virus infection. Virchows Arch. 2006;448:344-353. [PMID: 16261379 DOI: 10.1007/s00428-005-0066-4] [Cited by in Crossref: 52] [Cited by in F6Publishing: 55] [Article Influence: 3.1] [Reference Citation Analysis]
107 Sekizawa K, Nakagawa K, Ichikawa Y, Suwa H, Ozawa M, Momiyama M, Ishibe A, Watanabe J, Ota M, Kato I, Endo I. Relationship between stromal regulatory T cells and the response to neoadjuvant chemotherapy for locally advanced rectal cancer. Surg Today 2021. [PMID: 34081199 DOI: 10.1007/s00595-021-02311-8] [Reference Citation Analysis]
108 Rodriguez-salas N, Dominguez G, Barderas R, Mendiola M, García-albéniz X, Maurel J, Batlle JF. Clinical relevance of colorectal cancer molecular subtypes. Critical Reviews in Oncology/Hematology 2017;109:9-19. [DOI: 10.1016/j.critrevonc.2016.11.007] [Cited by in Crossref: 50] [Cited by in F6Publishing: 54] [Article Influence: 10.0] [Reference Citation Analysis]
109 Coppola D, Nebozhyn M, Khalil F, Dai H, Yeatman T, Loboda A, Mulé JJ. Unique ectopic lymph node-like structures present in human primary colorectal carcinoma are identified by immune gene array profiling. Am J Pathol 2011;179:37-45. [PMID: 21703392 DOI: 10.1016/j.ajpath.2011.03.007] [Cited by in Crossref: 157] [Cited by in F6Publishing: 140] [Article Influence: 14.3] [Reference Citation Analysis]
110 Suzuki O, Eguchi H, Chika N, Sakimoto T, Ishibashi K, Kumamoto K, Tamaru JI, Tachikawa T, Akagi K, Arai T, Okazaki Y, Ishida H. Prevalence and clinicopathologic/molecular characteristics of mismatch repair-deficient colorectal cancer in the under-50-year-old Japanese population. Surg Today 2017;47:1135-46. [PMID: 28258479 DOI: 10.1007/s00595-017-1486-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
111 Wood P, Peirce C, Mulsow J. Non-surgical factors influencing lymph node yield in colon cancer. World J Gastrointest Oncol 2016; 8(5): 466-473 [PMID: 27190586 DOI: 10.4251/wjgo.v8.i5.466] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
112 Zlobec I, Minoo P, Terracciano L, Baker K, Lugli A. Characterization of the immunological microenvironment of tumour buds and its impact on prognosis in mismatch repair-proficient and -deficient colorectal cancers. Histopathology 2011;59:482-95. [PMID: 22034888 DOI: 10.1111/j.1365-2559.2011.03975.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
113 Chiba T, Ohtani H, Mizoi T, Naito Y, Sato E, Nagura H, Ohuchi A, Ohuchi K, Shiiba K, Kurokawa Y, Satomi S. Intraepithelial CD8+ T-cell-count becomes a prognostic factor after a longer follow-up period in human colorectal carcinoma: possible association with suppression of micrometastasis. Br J Cancer. 2004;91:1711-1717. [PMID: 15494715 DOI: 10.1038/sj.bjc.6602201] [Cited by in Crossref: 124] [Cited by in F6Publishing: 124] [Article Influence: 6.9] [Reference Citation Analysis]
114 Li A, Felix JC, Hao J, Minoo P, Jain JK. Menstrual-like breakdown and apoptosis in human endometrial explants. Hum Reprod 2005;20:1709-19. [PMID: 15734750 DOI: 10.1093/humrep/deh824] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
115 Toh JWT, de Souza P, Lim SH, Singh P, Chua W, Ng W, Spring KJ. The Potential Value of Immunotherapy in Colorectal Cancers: Review of the Evidence for Programmed Death-1 Inhibitor Therapy. Clin Colorectal Cancer. 2016;15:285-291. [PMID: 27553906 DOI: 10.1016/j.clcc.2016.07.007] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 7.7] [Reference Citation Analysis]
116 Shunyakov L, Ryan CK, Sahasrabudhe DM, Khorana AA. The influence of host response on colorectal cancer prognosis. Clin Colorectal Cancer 2004;4:38-45. [PMID: 15207019 DOI: 10.3816/ccc.2004.n.008] [Cited by in Crossref: 33] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
117 Nordholm-Carstensen A, Krarup PM, Morton D, Harling H; Danish Colorectal Cancer Group. Mismatch repair status and synchronous metastases in colorectal cancer: A nationwide cohort study. Int J Cancer 2015;137:2139-48. [PMID: 25921209 DOI: 10.1002/ijc.29585] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
118 Jochems C, Schlom J. Tumor-infiltrating immune cells and prognosis: the potential link between conventional cancer therapy and immunity. Exp Biol Med (Maywood) 2011;236:567-79. [PMID: 21486861 DOI: 10.1258/ebm.2011.011007] [Cited by in Crossref: 181] [Cited by in F6Publishing: 166] [Article Influence: 16.5] [Reference Citation Analysis]
119 Meijer TW, Hoogerbrugge N, Nagengast FM, Ligtenberg MJ, van Krieken JH. In Lynch syndrome adenomas, loss of mismatch repair proteins is related to an enhanced lymphocytic response. Histopathology 2009;55:414-22. [PMID: 19817892 DOI: 10.1111/j.1365-2559.2009.03403.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
120 Manz SM, Losa M, Fritsch R, Scharl M. Efficacy and side effects of immune checkpoint inhibitors in the treatment of colorectal cancer. Therap Adv Gastroenterol 2021;14:17562848211002018. [PMID: 33948110 DOI: 10.1177/17562848211002018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
121 Umeto H, Yoshida T, Araki K, Yagishita H, Mikami T, Okayasu I. Appearance of epithelial and stromal genomic instability in background colorectal mucosa of sporadic colorectal cancer patients: relation to age and gender. J Gastroenterol. 2009;44:1036-1045. [PMID: 19590931 DOI: 10.1007/s00535-009-0103-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
122 Allard MA, Bachet JB, Beauchet A, Julie C, Malafosse R, Penna C, Nordlinger B, Emile JF. Linear quantification of lymphoid infiltration of the tumor margin: a reproducible method, developed with colorectal cancer tissues, for assessing a highly variable prognostic factor. Diagn Pathol. 2012;7:156. [PMID: 23148481 DOI: 10.1186/1746-1596-7-156] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
123 Sinicrope FA, Rego RL, Ansell SM, Knutson KL, Foster NR, Sargent DJ. Intraepithelial effector (CD3+)/regulatory (FoxP3+) T-cell ratio predicts a clinical outcome of human colon carcinoma. Gastroenterology. 2009;137:1270-1279. [PMID: 19577568 DOI: 10.1053/j.gastro.2009.06.053] [Cited by in Crossref: 193] [Cited by in F6Publishing: 193] [Article Influence: 14.8] [Reference Citation Analysis]
124 Trojan J, Brieger A, Raedle J, Weber N, Kriener S, Kronenberger B, Caspary WF, Zeuzem S. BAX and caspase-5 frameshift mutations and spontaneous apoptosis in colorectal cancer with microsatellite instability. Int J Colorectal Dis. 2004;19:538-544. [PMID: 15088110 DOI: 10.1007/s00384-004-0597-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
125 Perez RO, Habr-gama A, dos Santos RMN, Proscurshim I, Campos FG, Rawet V, Kiss D, Cecconello I. Peritumoral Inflammatory Infiltrate is not a Prognostic Factor in Distal Rectal Cancer Following Neoadjuvant Chemoradiation Therapy. J Gastrointest Surg 2007;11:1534-40. [DOI: 10.1007/s11605-007-0287-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
126 Walker J, Quirke P. Biology and genetics of colorectal cancer. Eur J Cancer. 2001;37 Suppl 7:S163-S172. [PMID: 11887987 DOI: 10.1016/s0959-8049(01)80018-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
127 Houston AM, Michael-Robinson JM, Walsh MD, Cummings MC, Ryan AE, Lincoln D, Pandeya N, Jass JR, Radford-Smith GL, O'Connell J. The "Fas counterattack" is not an active mode of tumor immune evasion in colorectal cancer with high-level microsatellite instability. Hum Pathol 2008;39:243-50. [PMID: 17961631 DOI: 10.1016/j.humpath.2007.06.010] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
128 Sinicrope FA, Rego RL, Garrity-park MM, Foster NR, Sargent DJ, Goldberg RM, Wiesenfeld M, Witzig TE, Thibodeau SN, Burgart LJ. Alterations in cell proliferation and apoptosis in colon cancers with microsatellite instability. Int J Cancer 2007;120:1232-8. [DOI: 10.1002/ijc.22429] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
129 Tougeron D, Fauquembergue E, Rouquette A, Le Pessot F, Sesboüé R, Laurent M, Berthet P, Mauillon J, Di Fiore F, Sabourin JC. Tumor-infiltrating lymphocytes in colorectal cancers with microsatellite instability are correlated with the number and spectrum of frameshift mutations. Mod Pathol. 2009;22:1186-1195. [PMID: 19503063 DOI: 10.1038/modpathol.2009.80] [Cited by in Crossref: 99] [Cited by in F6Publishing: 103] [Article Influence: 7.6] [Reference Citation Analysis]
130 Turano M, Delrio P, Rega D, Cammarota F, Polverino A, Duraturo F, Izzo P, De Rosa M. Promising Colorectal Cancer Biomarkers for Precision Prevention and Therapy. Cancers (Basel) 2019;11:E1932. [PMID: 31817090 DOI: 10.3390/cancers11121932] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
131 Asaka S, Arai Y, Nishimura Y, Yamaguchi K, Ishikubo T, Yatsuoka T, Tanaka Y, Akagi K. Microsatellite instability-low colorectal cancer acquires a KRAS mutation during the progression from Dukes’ A to Dukes’ B. Carcinogenesis. 2009;30:494-499. [PMID: 19147861 DOI: 10.1093/carcin/bgp017] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 3.7] [Reference Citation Analysis]
132 Bellizzi AM, Frankel WL. Colorectal cancer due to deficiency in DNA mismatch repair function: a review. Adv Anat Pathol. 2009;16:405-417. [PMID: 19851131 DOI: 10.1097/pap.0b013e3181bb6bdc] [Cited by in Crossref: 93] [Cited by in F6Publishing: 44] [Article Influence: 7.8] [Reference Citation Analysis]